IgY antibodies against cytolysin reduce ethanol-induced liver disease in mice
Authors:
- Noemí CabréNCNoemí Cabré
- Phillipp HartmannPHPhillipp Hartmann
- Cristina LlorenteCLCristina Llorente
- Tetsuya KounoTKTetsuya Kouno
- Yanhan WangYWYanhan Wang
- Suling ZengSZSuling Zeng
- Hyun Young KimHKHyun Young Kim
- Xinlian ZhangXZXinlian Zhang
- Tatiana KisselevaTKTatiana Kisseleva
- Subramanian IyerSISubramanian Iyer
- Sirisha KudumalaSKSirisha Kudumala
- Bernd SchnablBSBernd Schnabl
- 23 February 2023
- journal article
- research article
- Published by Wolters Kluwer Health in Hepatology
- Vol. 78 (1) , 295-306
Abstract
Background and Aims: Patients with severe alcohol-associated hepatitis have high morbidity and mortality. Novel therapeutic approaches are urgently needed. The aims of our study were to confirm the predictive value of cytolysin-positive Enterococcus faecalis (E. faecalis) for mortality in patients with alcohol-associated hepatitis and to assess the protective effect of specific chicken immunoglobulin Y (IgY) antibodies against cytolysin in vitro and in a microbiota-humanized mouse model of ethanol-induced liver disease. Approach and Results: We investigated a multicenter cohort of 26 subjects with alcohol-associated hepatitis and confirmed our previous findings that the presence of fecal cytolysin-positive E. faecalis predicted 180-day mortality in those patients. After combining this smaller cohort with our previously published multicenter cohort, the presence of fecal cytolysin has a better diagnostic area under the curve, better other accuracy measures, and a higher odds ratio to predict death in patients with alcohol-associated hepatitis than other commonly used liver disease models. In a precision medicine approach, we generated IgY antibodies against cytolysin from hyperimmunized chickens. Neutralizing IgY antibodies against cytolysin reduced cytolysin-induced cell death in primary mouse hepatocytes. The oral administration of IgY antibodies against cytolysin decreased ethanol-induced liver disease in gnotobiotic mice colonized with stool from cytolysin-positive patients with alcohol-associated hepatitis. Conclusions: E. faecalis cytolysin is an important mortality predictor in alcohol-associated hepatitis patients, and its targeted neutralization through specific antibodies improves ethanol-induced liver disease in microbiota-humanized mice.Keywords
This publication has 27 references indexed in Scilit:
- Gastric acid suppression promotes alcoholic liver disease by inducing overgrowth of intestinal EnterococcusNature Communications, 2017
- Alcoholic hepatitis histological score has high accuracy to predict 90-day mortality and response to steroidsDigestive and Liver Disease, 2016
- IgY antibodies in human nutrition for disease preventionNutrition Journal, 2015
- A Histologic Scoring System for Prognosis of Patients With Alcoholic HepatitisGastroenterology, 2014
- Structure, Function, and Biology of the Enterococcus faecalis CytolysinToxins, 2013
- Mouse model of chronic and binge ethanol feeding (the NIAAA model)Nature Protocols, 2013
- IgY Antibodies Protect against Human Rotavirus Induced Diarrhea in the Neonatal Gnotobiotic Piglet Disease ModelPLOS ONE, 2012
- The intestinal microbiome and the leaky gut as therapeutic targets in alcoholic liver diseaseFrontiers in Physiology, 2012
- Binding of avian IgY to type VII collagen does not activate complement and leucocytes and fails to induce subepidermal blistering in miceBritish Journal of Dermatology, 2008
- Suppressive Effect of Functional Drinking Yogurt Containing Specific Egg Yolk Immunoglobulin on Helicobacter pylori in HumansJournal of Dairy Science, 2004